Form 10-Q CONCERT PHARMACEUTICALS, For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Concert Pharma (CNCE) Tops Q3 EPS by 6c
November 12, 2014 8:20 AM ESTConcert Pharma (NASDAQ: CNCE) reported Q3 EPS of ($0.43), $0.06 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $4.4 million versus the consensus estimate of $1.67 million.
For earnings history and earnings-related data on Concert Pharma (CNCE) click here.
... More


